HighTower Advisors’s NRC Health Common Stock NRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-12,829
Closed -$590K 3354
2021
Q2
$590K Buy
12,829
+101
+0.8% +$4.8K ﹤0.01% 1956
2021
Q1
$597K Buy
12,728
+1,719
+16% +$83.5K ﹤0.01% 1874
2020
Q4
$467K Buy
11,009
+183
+2% +$9.39K ﹤0.01% 1671
2020
Q3
$532K Buy
10,826
+1,124
+12% +$62.2K ﹤0.01% 1543
2020
Q2
$567K Buy
9,702
+3,335
+52% +$176K ﹤0.01% 1392
2020
Q1
$289K Buy
6,367
+1,201
+23% +$72.1K ﹤0.01% 1593
2019
Q4
$338K Buy
5,166
+841
+19% +$51.4K ﹤0.01% 1643
2019
Q3
$249K Buy
+4,325
New +$268K ﹤0.01% 1922

Other funds holding NRC

HighTower Advisors's NRC Position: Q3 2021 in Review

HighTower Advisors sold out of NRC Health Common Stock (NRC) in Q3 2021, closing a stake of 12,829 shares — an estimated $590K sold.

HighTower Advisors first reported a position in NRC in Q3 2019 and held it in 8 quarters. The position peaked at $597K in Q1 2021. 109 funds tracked by Wall St. Rank hold NRC as of Q3 2021.

  • HighTower Advisors reported no remaining NRC Health Common Stock position as of Q3 2021 after selling out during the quarter.
  • HighTower Advisors sold 12,829 NRC Health Common Stock shares in Q3 2021, an estimated $590K.
  • HighTower Advisors first reported a position in NRC Health Common Stock in Q3 2019 and held it in 8 quarters.
  • HighTower Advisors's NRC Health Common Stock position peaked at $597K in Q1 2021.
  • 109 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q3 2021.

Based on HighTower Advisors's 13F filing for Q3 2021, filed 12 Nov 2021.